Adagene

Developer of immunotherapy for the treatment of cancer

placeSuzhou, Jiangsu, China calendar_todayFounded 2012 groups15 employees language adagene.com

Registered entities

Social engagement

Social engagement: 4.9K social following, 10 posts in the last 12 months — around the industry typical range.

Investor mix

14 investors on record; lead investors include General Atlantic, Eight Roads Ventures, F-Prime Capital, Sequoia Capital; 2 have since exited.

Investor typeCountShare
Venture capital536%
Private equity214%
Other / undisclosed750%

Recent activity

23 Apr 2026
Milestone
regulatory
20 Apr 2026
Event
AACR2026
14 Apr 2026
Leadership hire
Scientific & Strategic Advisory Board member
Coming soon